Sava funding
The short answer
Sava has one funding round on record, totalling about $35M in disclosed capital. Its latest (Series B) was €32.08 million, reported 2026-10-09, with Ascensia named as investors.
- Disclosed total
- $35M
- Rounds logged
- 1
- Latest round
- Series B
- Sector
- Health
Every round on record
| Date | Amount | Round | Investors | Source |
|---|---|---|---|---|
| 2026-10-09 | €32.08 million | Series B | Ascensia | EU-Startups |
Other recent Health rounds
- Neela Biotech£2.1 million · 2026-10-08
- CureMeAbroad$1.1 Mn · 2026-10-07
- Cori Clinical€3.56 million · 2026-10-07
- Healthleap$38M · 2026-10-07
- Vocca$20M · 2026-10-07
- WhiteLab Genomics€23.2 million · 2026-10-06
- Breye Therapeutics€67.5 million · 2026-10-02
- Omnio€2.9 million · 2026-10-02
How this is measured
Rounds are logged from public announcements and the outlet credited in the source column. Amounts are as reported; nothing is estimated. If a figure is wrong or a round is missing, send it via the corrections page.